The Journal of Hematology Oncology Pharmacy (JHOP) seeks to provide hematology and oncology pharmacy practitioners and other hematology oncology professionals with high-quality peer—reviewed information to help them optimize drug therapy for patients. The journal will be split into four major sections.

Neuroendocrine tumors (NETs) represent a spectrum of rare neoplasms derived from cells of the nervous and endocrine systems.

Bevacizumab-based Therapy Improves Outcomes in Elderly Patients with NSCLC
Background: Efficacy and safety data of bevacizu mab plus cisplatin/gemcitabine for elderly patients with non–small-cell lung cancer (NSCLC) could be extracted through subgroup analysis of patients in the AVAiL trial.


Results 1 - 8 of 8